Skip to main content

Table 3 Measures and schedule of phase II a

From: Combining motivational and volitional strategies to promote unsupervised walking in patients with fibromyalgia: study protocol for a randomized controlled trial

 

Instrument

Schedule

Outcomes

Baseline

Week 7

Week 20 (3 months)

Week 43 (9 months)

Primary

     

Walking pattern

Ad hoc self-report scale

X

X

X

X

Daily logs

 

X

X

X

Steps and distance

Pedometerb

 

X

X

X

Secondary

     

Total physical activity

IPAQ

X

X

X

X

Intense physical activity

 

X

X

X

X

Moderate physical activity

 

X

X

X

X

Walking

 

X

X

X

X

Sitting

 

X

X

X

X

Physical function

Six-Minute Walk Test

X

X

X

X

FM Impact

FIQ

X

X

X

X

Pain intensity

Ad hoc scale

X

X

X

X

Emotional status: Distress

HADS

X

X

X

X

Mediators

     

Behavioral intentionc

TPB items

X

X

X

X

Implementation intentionsc

Ad hoc items

 

X

X

X

  1. aFIQ: Fibromyalgia Impact Questionnaire; HADS: Hospital Anxiety and Depression Scale; IPAQ: International Physical Activity Questionnaire; TPB: Theory of Planned Behavior. bLimit of recording is 60 days. cAlso measured at the end of the intervention sessions.